Alpha Tau Medical (NASDAQ: DRTS ) is pioneering the first and (as far as we are aware) only way of delivering alpha particle radiation locally to solid tumors. While the company is not currently well known, this represents a potentially significant breakthrough in oncologyAnalyst’s Disclosure:I/we have a beneficial long position in the shares of DRTS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation f ...